Investor Relations

We’re at the forefront of rare disease diagnostic testing, with a primary focus on pediatric and outpatient NICU testing in order to find diagnoses early in a patient’s life. While rare and complex disease patients are our current focus, we believe that everyone can benefit from exome and genome testing. We envision a healthcare system in which an individual’s genomic profile can be paired with their clinical data to deliver personalized health plans and treatment options throughout their lives.